Using nature’s innate intelligence to eliminate cancer.

ImmuneBridge is developing a new generation of allogeneic cell therapies to make cancer cures accessible to everyone.

OUR SCIENCE

Our proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency—to create a diverse, consistent, and abundant cellular source for immunotherapies, rooted in the immune lineage.

 

Join our team.

Every employee has independence, trust, and influence. Positions are based in San Francisco across roles in research, analytics, operations, and process development. If you’re excited about working at ImmuneBridge, please reach out to careers@immunebridge.com.

Our Leadership

We’re scientists and engineers working to make curative cell therapies available to everyone.

S. Alex Jacobson

interim CEO

Nina Horowitz

Chief scientific officer

Tom Farrell

Board of Directors

Nadiya Ishnazarova

Board of Directors

Dylan Morris

Board of Directors

Alicia Jackson

Board of Directors